IIT Kanpur has licensed a pioneering technology to Reliance Life Sciences Pvt. Ltd. that has the potential to revolutionize the field of gene therapy, especially for many genetic eye diseases, making it the first time that a gene therapy related technology has been developed and transferred from an academic institution to a company in India.
A novel, minimally invasive surgical technique for correcting blepharoptosis – often called “droopy eyelid” – is more efficient and produces better results than the traditional method that uses sutures, according to a UT Southwestern Medical Center study. The findings, reported in the American Journal of Ophthalmology, may lead to a shift in how oculoplastic surgeons treat this common condition.
The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.
Established in 1995, the Glaucoma Foundation's Annual Think Tank has significantly increased the number of people around the world working in the field of glaucoma. All of the speakers at this 2-day will attend in person and the conference will be live-streamed on Zoom.
Last month at its 2023 Annual Meeting in New Orleans, La., the Association for Research in Vision and Ophthalmology (ARVO) welcomed Patricia A. D’Amore, PhD, MBA, FARVO, as its new president for April 2023 – May 2024. A member for more than 40 years, D’Amore is a Gold Fellow of ARVO (FARVO) ― a recognition of her individual accomplishments, leadership, and contributions to the Association.
Donors, patients, the board of directors, and volunteers joined together to mark an important milestone in Glaucoma Research Foundation’s history of innovation and collaboration. Ruth Williams, MD, Vice-Chair of the Board of Directors, was the keynote speaker.
Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines.
Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.
We are quite good at spotting unexpected objects while focused on another activity if they are moving fast, reveals a new study by a team of New York University researchers.
The Robert Ritch Award recognizes the contributions of individuals who have played a significant and unique role in promoting the medicine and science of glaucoma.
Blood vessel abnormalities in the eye are a major factor in the progression of Alzheimer’s disease, according to research from Cedars-Sinai investigators published in the peer-reviewed journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
Our hands do more than just hold objects. They also facilitate the processing of visual stimuli. When you move your hands, your brain first perceives and interprets sensory information, then it selects the appropriate motor plan before initiating and executing the desired movement.
BGSU is partnering with public and private organizations to provide the U.S. Department of Defense with eyewear that electronically adjusts its tint from clear to dark in 0.1 seconds, a critical safety feature.
Researchers at NIH’s National Eye Institute have published a detailed protocol for making three cell types that are key components to form blood vessels and capillaries.
Mobius Therapeutics™, LLC, a St. Louis-based perioperative ophthalmic pharmaceutical company, will initiate a series of professional education sessions, focused on how end users of Mitosol® can achieve compliance with USP <800>, the soon to be implemented and enforced standards for control of hazardous drugs in healthcare facilities.
The Truhlsen-Marmor Museum of the Eye®, the world’s only free, public museum dedicated to the science of sight, today announced the opening of Decoding the Eye: Signs and Symbols, a new exhibit exploring how the eye appears as a symbol throughout time.
The study, published on 8 May in the journal PLOS ONE, explored the computational mechanisms used by the human brain to perceive the size of objects in the world around us.
In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).
Glaucoma Research Foundation (GRF), a national non-profit organization dedicated to finding a cure for glaucoma, has selected visually impaired professional triathlete Amy Dixon as keynote speaker for its 2023 Patient Summit, to be held in Long Beach, California, June 23-24.
Advances in early detection and treatment of retinal diseases made possible by retina specialists can preserve sight and virtually eliminate vision loss from conditions such as age-related macular degeneration (AMD), diabetic retinopathy and retinal detachment.
Showing results
1–20 of 2112
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
